Tabradol (Fusion Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Tabradol drug offered from Fusion Pharmaceuticals LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fusion Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | Cyclobenzaprine Hydrochloride |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2009-09-17 |
| END MARKETING DATE: | 0000-00-00 |
Tabradol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tabradol from Fusion Pharmaceuticals LLC |
| LABELER NAME: | Fusion Pharmaceuticals LLC |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2009-09-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43093-101_28c7b9e3-07ca-6f9b-e054-00144ff88e88 |
| PRODUCT NDC: | 43093-101 |
| APPLICATION NUMBER: |